407 related articles for article (PubMed ID: 11276250)
1. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping.
Janowski R; Kozak M; Jankowska E; Grzonka Z; Grubb A; Abrahamson M; Jaskolski M
Nat Struct Biol; 2001 Apr; 8(4):316-20. PubMed ID: 11276250
[TBL] [Abstract][Full Text] [Related]
2. Domain swapping in N-truncated human cystatin C.
Janowski R; Abrahamson M; Grubb A; Jaskolski M
J Mol Biol; 2004 Jul; 341(1):151-60. PubMed ID: 15312769
[TBL] [Abstract][Full Text] [Related]
3. 3D domain-swapped human cystatin C with amyloidlike intermolecular beta-sheets.
Janowski R; Kozak M; Abrahamson M; Grubb A; Jaskolski M
Proteins; 2005 Nov; 61(3):570-8. PubMed ID: 16170782
[TBL] [Abstract][Full Text] [Related]
4. 3D domain swapping, protein oligomerization, and amyloid formation.
Jaskólski M
Acta Biochim Pol; 2001; 48(4):807-27. PubMed ID: 11995994
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of human cystatin C stabilized against amyloid formation.
Kolodziejczyk R; Michalska K; Hernandez-Santoyo A; Wahlbom M; Grubb A; Jaskolski M
FEBS J; 2010 Apr; 277(7):1726-37. PubMed ID: 20175878
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for amyloidosis related to hereditary brain hemorrhage.
Abrahamson M
Scand J Clin Lab Invest Suppl; 1996; 226():47-56. PubMed ID: 8981667
[TBL] [Abstract][Full Text] [Related]
7. NMR structural studies of human cystatin C dimers and monomers.
Ekiel I; Abrahamson M; Fulton DB; Lindahl P; Storer AC; Levadoux W; Lafrance M; Labelle S; Pomerleau Y; Groleau D; LeSauteur L; Gehring K
J Mol Biol; 1997 Aug; 271(2):266-77. PubMed ID: 9268658
[TBL] [Abstract][Full Text] [Related]
8. Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C.
Gerhartz B; Ekiel I; Abrahamson M
Biochemistry; 1998 Dec; 37(49):17309-17. PubMed ID: 9860845
[TBL] [Abstract][Full Text] [Related]
9. Hinge-loop mutation can be used to control 3D domain swapping and amyloidogenesis of human cystatin C.
Orlikowska M; Jankowska E; Kołodziejczyk R; Jaskólski M; Szymańska A
J Struct Biol; 2011 Feb; 173(2):406-13. PubMed ID: 21074623
[TBL] [Abstract][Full Text] [Related]
10. Checking the conformational stability of cystatin C and its L68Q variant by molecular dynamics studies: why is the L68Q variant amyloidogenic?
Rodziewicz-Motowidło S; Wahlbom M; Wang X; Lagiewka J; Janowski R; Jaskólski M; Grubb A; Grzonka Z
J Struct Biol; 2006 Apr; 154(1):68-78. PubMed ID: 16446102
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulations to investigate the domain swapping mechanism of human cystatin C.
Lin YM; Liu HL; Zhao JH; Huang CH; Fang HW; Ho Y; Chen WY
Biotechnol Prog; 2007; 23(3):577-84. PubMed ID: 17439156
[TBL] [Abstract][Full Text] [Related]
12. The role of the Val57 amino-acid residue in the hinge loop of the human cystatin C. Conformational studies of the beta2-L1-beta3 segments of wild-type human cystatin C and its mutants.
Rodziewicz-Motowidło S; Iwaszkiewicz J; Sosnowska R; Czaplewska P; Sobolewski E; Szymańska A; Stachowiak K; Liwo A
Biopolymers; 2009 May; 91(5):373-83. PubMed ID: 19137579
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulations of human cystatin C and its L68Q varient to investigate the domain swapping mechanism.
Liu HL; Lin YM; Zhao JH; Hsieh MC; Lin HY; Huang CH; Fang HW; Ho Y; Chen WY
J Biomol Struct Dyn; 2007 Oct; 25(2):135-44. PubMed ID: 17718592
[TBL] [Abstract][Full Text] [Related]
14. Physico-chemical properties of the N-terminally truncated L68Q cystatin C found in amyloid deposits of brain haemorrhage patients.
Gerhartz B; Abrahamson M
Biol Chem; 2002 Feb; 383(2):301-5. PubMed ID: 11934268
[TBL] [Abstract][Full Text] [Related]
15. Comparison of backbone dynamics of monomeric and domain-swapped stefin A.
Japelj B; Waltho JP; Jerala R
Proteins; 2004 Feb; 54(3):500-12. PubMed ID: 14747998
[TBL] [Abstract][Full Text] [Related]
16. Role of the amino acid sequence in domain swapping of the B1 domain of protein G.
Sirota FL; Héry-Huynh S; Maurer-Stroh S; Wodak SJ
Proteins; 2008 Jul; 72(1):88-104. PubMed ID: 18186476
[TBL] [Abstract][Full Text] [Related]
17. Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping.
Wahlbom M; Wang X; Lindström V; Carlemalm E; Jaskolski M; Grubb A
J Biol Chem; 2007 Jun; 282(25):18318-18326. PubMed ID: 17470433
[TBL] [Abstract][Full Text] [Related]
18. Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C.
Nilsson M; Wang X; Rodziewicz-Motowidlo S; Janowski R; Lindström V; Onnerfjord P; Westermark G; Grzonka Z; Jaskolski M; Grubb A
J Biol Chem; 2004 Jun; 279(23):24236-45. PubMed ID: 15028721
[TBL] [Abstract][Full Text] [Related]
19. Distinct properties of wild-type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type.
Calero M; Pawlik M; Soto C; Castaño EM; Sigurdsson EM; Kumar A; Gallo G; Frangione B; Levy E
J Neurochem; 2001 Apr; 77(2):628-37. PubMed ID: 11299325
[TBL] [Abstract][Full Text] [Related]
20. Mechanism and energy landscape of domain swapping in the B1 domain of protein G.
Malevanets A; Sirota FL; Wodak SJ
J Mol Biol; 2008 Sep; 382(1):223-35. PubMed ID: 18588900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
